Published in PLoS One on June 21, 2010
Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models. Genome Biol (2015) 1.46
Reactive oxygen species in cancer stem cells. Antioxid Redox Signal (2012) 1.44
MicroRegulators come of age in senescence. Trends Genet (2011) 1.42
Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol (2012) 1.36
Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med (2013) 1.30
MiRNA in innate immune responses: novel players in wound inflammation. Physiol Genomics (2010) 1.25
Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells. BMC Cancer (2012) 1.10
Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics (2014) 1.09
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget (2015) 1.08
miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res (2014) 1.08
MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ Res (2012) 1.04
Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Cancer (2012) 1.01
Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal (2012) 1.01
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Adv Drug Deliv Rev (2014) 1.00
NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. Oncogenesis (2013) 0.97
MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem (2012) 0.96
Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer (2014) 0.96
Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis. J Cell Sci (2013) 0.94
Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells. BMC Res Notes (2012) 0.94
Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS One (2011) 0.93
Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells. J Neurooncol (2012) 0.93
Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer. PLoS One (2013) 0.90
Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy. Neurotherapeutics (2013) 0.85
Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells. Stem Cells Dev (2012) 0.84
Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies. Brain Pathol (2011) 0.82
Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma. Front Oncol (2013) 0.81
MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons. Int J Mol Sci (2014) 0.81
Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol (2013) 0.81
Cancer stem cells in breast cancer. Cancers (Basel) (2011) 0.80
The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma. J Clin Med (2016) 0.80
Deregulated proliferation and differentiation in brain tumors. Cell Tissue Res (2014) 0.80
microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma. PLoS One (2015) 0.80
Hedgehog/GLI signaling activates suppressor of cytokine signaling 1 (SOCS1) in epidermal and neural tumor cells. PLoS One (2013) 0.79
Regulation of NANOG in cancer cells. Mol Carcinog (2015) 0.79
Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging. Age (Dordr) (2013) 0.79
Noncoding RNA control of cellular senescence. Wiley Interdiscip Rev RNA (2015) 0.79
MicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion Injury. Int J Mol Sci (2015) 0.78
Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma. PLoS One (2015) 0.78
MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown. J Hematol Oncol (2015) 0.77
BMI1: A Biomarker of Hematologic Malignancies. Biomark Cancer (2016) 0.77
IDH1R132H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a. Mol Med Rep (2015) 0.77
Antitumor activity and inhibitory effects on cancer stem cell-like properties of Adeno-associated virus (AAV) -mediated Bmi-1 interference driven by Bmi-1 promoter for gastric cancer. Oncotarget (2016) 0.77
Interplay between Reactive oxygen Species and MicroRNAs in Cancer. Curr Pharmacol Rep (2016) 0.77
miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells. Immunogenetics (2013) 0.76
A step-by-step microRNA guide to cancer development and metastasis. Cell Oncol (Dordr) (2017) 0.75
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism. Front Physiol (2016) 0.75
Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulo-matosis with Polyangiitis. Curr Genomics (2015) 0.75
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment. J Clin Med (2017) 0.75
Hyperosmotic stress activates the expression of members of the miR-15/107 family and induces downregulation of anti-apoptotic genes in rat liver. Sci Rep (2015) 0.75
Negative regulation of Bmi-1 by AMPK and implication in cancer progression. Oncotarget (2016) 0.75
MicroRNA-128-3p regulates mitomycin C-induced DNA damage response in lung cancer cells through repressing SPTAN1. Oncotarget (2016) 0.75
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
The functions of animal microRNAs. Nature (2004) 64.85
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
Identification of human brain tumour initiating cells. Nature (2004) 38.87
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature (2003) 11.23
MicroRNAs regulate brain morphogenesis in zebrafish. Science (2005) 11.16
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A (2006) 10.65
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature (2009) 10.31
microPrimer: the biogenesis and function of microRNA. Development (2005) 8.19
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol (2006) 5.96
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med (2008) 5.91
Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev (2005) 5.78
Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature (2004) 4.82
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res (2008) 4.64
Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci (2005) 3.97
Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature (2009) 3.90
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res (2009) 3.03
MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res (2007) 2.90
The developmental biology of brain tumors. Annu Rev Neurosci (2001) 2.82
The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci U S A (2009) 2.72
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol (2005) 2.34
Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci U S A (1984) 2.28
MicroRNA profiling in human medulloblastoma. Int J Cancer (2009) 2.12
Medulloblastoma: developmental mechanisms out of control. Trends Mol Med (2005) 1.85
Free radicals and senescence. Exp Cell Res (2008) 1.79
Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol (2008) 1.72
Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer (2007) 1.62
Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol (1999) 1.53
Medulloblastoma: a problem of developmental biology. Cancer Cell (2002) 1.21
Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. Neuro Oncol (2007) 1.16
Advances in the treatment of pediatric brain tumors. Expert Rev Neurother (2004) 1.06
Dinstinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis. Mech Ageing Dev (2005) 0.93
Competency-based medical education: theory to practice. Med Teach (2010) 7.76
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med (2011) 2.54
Intramedullary spinal cord astrocytomas in children. Pediatr Blood Cancer (2004) 2.38
Competency-based medical education in postgraduate medical education. Med Teach (2010) 2.28
Electrostatic control of ions and molecules in nanofluidic transistors. Nano Lett (2005) 2.21
Controlled growth of Si nanowire arrays for device integration. Nano Lett (2005) 2.02
Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol (2012) 1.88
Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer (2010) 1.82
Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc Natl Acad Sci U S A (2011) 1.76
Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol (2008) 1.72
Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem (2002) 1.57
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst (2007) 1.53
Effects of biological reactions and modifications on conductance of nanofluidic channels. Nano Lett (2005) 1.50
Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res (2006) 1.50
Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano (2012) 1.47
Nephrogenic adenoma in the augmented bladder. J Urol (2011) 1.46
Antiarrhythmic effect mediated by κ-opioid receptor is associated with Cx43 stabilization. Crit Care Med (2010) 1.44
Cord blood transplant in childhood ALL. Pediatr Blood Cancer (2005) 1.43
The involvement of AMPA-ERK1/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate. Amino Acids (2012) 1.41
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
A vision and strategy for the virtual physiological human in 2010 and beyond. Philos Trans A Math Phys Eng Sci (2010) 1.33
Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol (2012) 1.33
Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage. Cancer Res (2010) 1.28
Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr (2006) 1.26
Brainstem ganglioglioma successfully treated with vemurafenib. J Clin Oncol (2013) 1.25
Protein signaling networks from single cell fluctuations and information theory profiling. Biophys J (2011) 1.21
Nanowire substrate-based laser scanning cytometry for quantitation of circulating tumor cells. Nano Lett (2012) 1.19
High-throughput secretomic analysis of single cells to assess functional cellular heterogeneity. Anal Chem (2013) 1.16
Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines. Pediatr Blood Cancer (2010) 1.15
Adherence to an exercise prescription scheme: the role of expectations, self-efficacy, stage of change and psychological well-being. Br J Health Psychol (2005) 1.15
Capsule endoscopy and bowel preparation with oral sodium phosphate: a prospective randomized controlled trial. Gastrointest Endosc (2008) 1.13
Reduced striatal dopamine transporters in people with internet addiction disorder. J Biomed Biotechnol (2012) 1.11
Chemistries for patterning robust DNA microbarcodes enable multiplex assays of cytoplasm proteins from single cancer cells. Chemphyschem (2010) 1.11
Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells. BMC Cancer (2012) 1.10
Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. Neuro Oncol (2012) 1.09
Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumour Biol (2012) 1.09
miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. Tumour Biol (2013) 1.07
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry (2008) 1.04
Localized cystic disease of the kidney: distinction from cystic neoplasms and hereditary polycystic diseases. Am J Surg Pathol (2013) 1.04
Signet-ring cell carcinoma of ampulla of Vater: contrast-enhanced ultrasound findings. World J Gastroenterol (2009) 1.02
Field-effect reconfigurable nanofluidic ionic diodes. Nat Commun (2011) 1.02
Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget (2014) 1.02
Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Cancer (2012) 1.01
One-step patterning of aligned nanowire arrays by programmed dip coating. Angew Chem Int Ed Engl (2007) 1.01
A quartz nanopillar hemocytometer for high-yield separation and counting of CD4(+) T lymphocytes. Nanoscale (2012) 1.01
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol (2011) 1.00
Association between CD14 gene C-260T polymorphism and inflammatory bowel disease: a meta-analysis. PLoS One (2012) 1.00
Nanofluidic diodes based on nanotube heterojunctions. Nano Lett (2009) 0.99
The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study. Hepatology (2014) 0.98
On the biomechanical role of glycosaminoglycans in the aortic heart valve leaflet. Acta Biomater (2012) 0.98
MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem (2012) 0.96
The transition out of medical school - a qualitative study of descriptions of borderline trainee interns. Med Educ (2002) 0.95
Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS One (2012) 0.95
The impact of working life on health behavior: the effect of job strain on the cognitive predictors of exercise. J Occup Health Psychol (2002) 0.94
Clinical capabilities of graduates of an outcomes-based integrated medical program. BMC Med Educ (2012) 0.94
Meranzin hydrate induces similar effect to Fructus Aurantii on intestinal motility through activation of H1 histamine receptors. J Gastrointest Surg (2011) 0.93
Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells. J Neurooncol (2012) 0.93
Aurora kinase A as a rational target for therapy in glioblastoma. J Neurosurg Pediatr (2010) 0.92
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China. Front Med (2014) 0.92
Inorganic nanotubes: a novel platform for nanofluidics. Acc Chem Res (2006) 0.92
Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. J Ethnopharmacol (2011) 0.91
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma. Mol Cancer (2014) 0.91
Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells. Neuro Oncol (2011) 0.91
Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells. Biomaterials (2012) 0.90
κ-Opioid receptor stimulation modulates TLR4/NF-κB signaling in the rat heart subjected to ischemia-reperfusion. Cytokine (2013) 0.90
The power of one: looking beyond the teacher in clinical instruction. Med Teach (2009) 0.90
[Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area]. Zhonghua Yi Xue Za Zhi (2003) 0.89
Nanophasic biodegradation enhances the durability and biocompatibility of magnesium alloys for the next-generation vascular stents. Nanoscale (2013) 0.89
Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome. Ann Hematol (2012) 0.89
Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies. Mol Biol Rep (2014) 0.89
Fast nonlinear ion transport via field-induced hydrodynamic slip in sub-20-nm hydrophilic nanofluidic transistors. Nano Lett (2009) 0.89
P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer (2003) 0.89
Pilomyxoid astrocytoma treated successfully with vemurafenib. Pediatr Blood Cancer (2014) 0.88
The effect of compound nutrients on stress-induced changes in serum IL-2, IL-6 and TNF-alpha levels in rats. Cytokine (2007) 0.88
Gone exercising: mental contrasting promotes physical activity among overweight, middle-aged, low-SES fishermen. Health Psychol (2012) 0.88
Is the presence of 6 or fewer crypt apoptotic bodies sufficient for diagnosis of graft versus host disease? A decade of experience at a single institution. Am J Surg Pathol (2013) 0.87
Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients. PLoS One (2012) 0.87
Bilateral testicular masses: an unusual presentation of neuroblastoma. Urology (2006) 0.87
A strategy for detecting optimal ratio of cardioprotection-dependent three compounds as quality control of guan-xin-er-hao formula. J Ethnopharmacol (2010) 0.87
Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells. J Neurooncol (2012) 0.86
Prevention and management of drug resistant hepatitis B virus infections. J Gastroenterol Hepatol (2012) 0.85
Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters. Int J Clin Exp Pathol (2013) 0.85
Exploring Australasian surgical trainees' satisfaction with operating theatre learning using the 'surgical theatre educational environment measure'. ANZ J Surg (2010) 0.85
[Diagnostic analysis of hospitalized patients with fever of unknown origin at department of infectious diseases]. Zhonghua Yi Xue Za Zhi (2011) 0.85
Threshold microsclerotial inoculum for cotton verticillium wilt determined through wet-sieving and real-time quantitative PCR. Phytopathology (2015) 0.84
Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China. J Gastroenterol Hepatol (2015) 0.84
A strategy for detecting absorbed bioactive compounds for quality control in the water extract of rhubarb by ultra performance liquid chromatography with photodiode array detector. Chin J Integr Med (2012) 0.84
Single cell functional proteomics for assessing immune response in cancer therapy: technology, methods, and applications. Front Oncol (2013) 0.84